Bio-Products outperforms the whole at Kyowa Hakko
This article was originally published in Clinica
Executive Summary
Kyowa Hakko (Japan) has reported a 9.5% sales increase in 1994 by its Pharmaceuticals and Bio-Products Division, which includes diagnostic reagents subsidiary Kyowa Medex. Turnover was ¥74,967 million ($2,083 million) compared with Yen158,892 million in 1993. Divisional operating income was up 26.3% at Yen28,730 million. Group turnover rose 5.7% to Yen341,545 million with net profits up 69% at Yen10,646 million.